Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Chang Wook Jeong
Affiliation
Seoul National University Hospital, Seoul National University College of Medicine
ORCID
Career Start Year
2005
Papers
316
H Index
29
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
38062708
Oncological Outcomes in Men with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide with versus without Confirmatory Bone Scan.
Cancer Res Treat
2024
35118841
Establishment of Prospective Registry of Active Surveillance for Prostate Cancer: The Korean Urological Oncology Society Database.
World J Mens Health
2023
37668201
Renal function change after radical cystectomy for urothelial carcinoma patients with a solitary kidney may be independent of urinary diversion type.
Investig Clin Urol
2023
37752996
Role of lymphatic invasion in predicting biochemical recurrence after radical prostatectomy.
Front Oncol
2023
37831155
Tubular damage marker as a predictive factor for pathologically upstaged renal cell carcinoma.
World J Urol
2023
37460568
Explainable ML models for a deeper insight on treatment decision for localized prostate cancer.
Sci Rep
2023
37118954
Observation, Radiotherapy, or Radical Prostatectomy for Localized Prostate Cancer: Survival Analysis in the United States.
World J Mens Health
2023
37417560
Pyuria as an independent predictor of intravesical recurrence after radical nephroureterectomy in patients with upper tract urothelial carcinoma.
Investig Clin Urol
2023
37417558
Comparative analysis of mortality and progression to end-stage renal disease between surgically induced and medical chronic kidney disease: A study using the National Health Insurance customized database.
Investig Clin Urol
2023
37417554
Unleashing the potential: Artificial intelligence in urology for enhanced diagnosis, treatment, and personalized care.
Investig Clin Urol
2023
37345184
Practical Utility of Liquid Biopsies for Evaluating Genomic Alterations in Castration-Resistant Prostate Cancer.
Cancers (Basel)
2023
36944962
Clinical features and Surgical Outcome of Clear Cell Papillary Renal Cell Tumor: result from a prospective cohort.
BMC Urol
2023
37031280
Machine learning based prediction for oncologic outcomes of renal cell carcinoma after surgery using Korean Renal Cell Carcinoma (KORCC) database.
Sci Rep
2023
36996119
Optimal management of renal cell carcinoma in octogenarians: Retrospective analysis using updated Korean Renal Cell Carcinoma (KORCC) database.
PLoS One
2023
36915877
Accuracy of actual stage prediction using Vesical Imaging Reporting and Data System (VI-RADS) before radical cystectomy for urothelial carcinoma in SUPER-UC-Cx.
Transl Androl Urol
2023
36464435
Sensitive electrochemical sensing platform based on Au nanoflower-integrated carbon fiber for detecting interleukin-6 in human serum.
Anal Chim Acta
2023
36534766
Feasibility, Safety, and Functional Outcomes of Pelvic Hypothermia Induced Using a Rectal Cooling Device During Robot-Assisted Radical Prostatectomy: A Phase I/II Trial.
J Endourol
2023
36571602
Fully automatic volume measurement of the adrenal gland on CT using deep learning to classify adrenal hyperplasia.
Eur Radiol
2023
36730281
Natural history of incidentally diagnosed prostate cancer after holmium laser enucleation of the prostate.
PLoS One
2023
36593042
Association of Volatile <i>Versus</i> Intravenous Anesthesia With Prognosis After Nephrectomy for Renal Cell Carcinoma.
In Vivo
2023
35945294
Long-term oncologic outcomes of robot-assisted versus open radical prostatectomy for prostate cancer with seminal vesicle invasion: a multi-institutional study with a minimum 5-year follow-up.
J Cancer Res Clin Oncol
2023
34015891
Prediction of Pathologic Findings with MRI-Based Clinical Staging Using the Bayesian Network Modeling in Prostate Cancer: A Radiation Oncologist Perspective.
Cancer Res Treat
2022
35676678
Clinical determinants of recurrence in pTa bladder cancer following transurethral resection of bladder tumor.
BMC Cancer
2022
35437958
Safety and feasibility of synchronous unilateral nephrectomy and contralateral heminephrectomy for extremely severe autosomal dominant polycystic kidney disease: Techniques and outcome.
Investig Clin Urol
2022
35796142
Feasibility study of a novel rectal cooling system for hypothermic radical prostatectomy in a swine model.
Investig Clin Urol
2022
35762185
Phase I Clinical Trial of Prostate-Specific Membrane Antigen-Targeting <sup>68</sup>Ga-NGUL PET/CT in Healthy Volunteers and Patients with Prostate Cancer.
Korean J Radiol
2022
35634584
Clinical Significances of Anti-Collagen Type I and Type III Antibodies in Antibody-Mediated Rejection.
Transpl Int
2022
35778831
Isolation and Genomic Analysis of Single Circulating Tumor Cell Using Human Telomerase Reverse Transcriptase and Desmoglein-2.
Small Methods
2022
35912192
High Carbohydrate Antigen 19-9 Levels Indicate Poor Prognosis of Upper Tract Urothelial Carcinoma.
Front Oncol
2022
36100881
Machine learning-based prediction model for late recurrence after surgery in patients with renal cell carcinoma.
BMC Med Inform Decis Mak
2022
36303834
Increased urinary B2-microglobulin is associated with poor prognosis of upper tract urothelial carcinoma.
Front Oncol
2022
36091123
Acidic urine is associated with poor prognosis in patients with bladder cancer undergoing radical cystectomy.
Front Oncol
2022
36347550
Comparison of functional and oncological outcomes between uterus-sparing radical cystectomy and standard radical cystectomy in females: A retrospective study.
Investig Clin Urol
2022
36344958
Association between decreased ipsilateral renal function and aggressive behavior in renal cell carcinoma.
BMC Cancer
2022
35123918
Geriatric assessment using the G8 to predict postoperative complications in patients undergoing major uro-oncologic surgery: Comparison with the Charlson Comorbidity Index.
J Geriatr Oncol
2022
35038250
Isolation and Genomic Analysis of Single Circulating Tumor Cell Using Human Telomerase Reverse Transcriptase and Desmoglein-2.
Small Methods
2022
35141155
Acidic Urine Is Associated With Poor Prognosis of Upper Tract Urothelial Carcinoma.
Front Oncol
2022
34645132
Next-generation Proteomics-Based Discovery, Verification, and Validation of Urine Biomarkers for Bladder Cancer Diagnosis.
Cancer Res Treat
2022
34752423
Kidney VISTA prevents IFN-γ/IL-9 axis-mediated tubulointerstitial fibrosis after acute glomerular injury.
J Clin Invest
2022
34508180
Active surveillance in intermediate-risk prostate cancer with PSA 10-20â¿¿ng/mL: pathological outcome analysis of a population-level database.
Prostate Cancer Prostatic Dis
2022
34350882
Efficacy of the Treatment of Intraperitoneal Bladder Perforation during Transurethral Resection of Bladder Tumor with the Urethral Catheter Alone: Retrospective Analysis of over 15 Years Using the Clinical Data Warehouse System.
Urol Int
2022
32869150
Role of multiparametric magnetic resonance imaging to predict postoperative Gleason score upgrading in prostate cancer with Gleason score 3â¿¿+â¿¿4.
World J Urol
2021
33542395
Prognostic significance of pathologic nodal positivity in non-metastatic patients with renal cell carcinoma who underwent radical or partial nephrectomy.
Sci Rep
2021
33637585
Head-to-Head Comparison of <sup>68</sup>Ga-NOTA (<sup>68</sup>Ga-NGUL) and <sup>68</sup>Ga-PSMA-11 in Patients with Metastatic Prostate Cancer: A Prospective Study.
J Nucl Med
2021
33527588
Targeted therapy response in early versus late recurrence of renal cell carcinoma after surgical treatment: A propensity score-matched study using the Korean Renal Cancer Study Group database.
Int J Urol
2021
33687832
Laparoscopic Ablation System for Complete Circumferential Renal Sympathetic Denervation.
IEEE Trans Biomed Eng
2021
35003352
Prognostic Impact of Preoperative Renal Insufficiency on Metastasis-Free Survival after Radical Cystectomy.
J Cancer
2021
34501211
Pyuria as a Predictive Marker of Bacillus Calmette-Guérin Unresponsiveness in Non-Muscle Invasive Bladder Cancer.
J Clin Med
2021
34575266
Estimated Glomerular Filtration Rate as a Prognostic Factor in Urothelial Carcinoma of the Upper Urinary Tract: A Systematic Review and Meta-Analysis.
J Clin Med
2021
34397846
Prognostic factors for overall survival in patients with clear cell metastatic renal cell carcinoma: Model development and external validation with Memorial Sloan Kettering Cancer Center model and the international metastatic renal cell carcinoma database consortium model.
Medicine (Baltimore)
2021
1 - 50 of 316
Column Actions
Search
Recommended Authors
Giovanni Motterle
Mayo Clinic
Career Start Year
2017
Number of shared co-authors
0
Jiayu Liang
institute of urology
Career Start Year
2016
Number of shared co-authors
0
Saum Ghodoussipour
Rutgers Cancer Institute of New Jersey
Career Start Year
2016
Number of shared co-authors
1
Jamil S Syed
Yale School of Medicine
Career Start Year
2015
Number of shared co-authors
0
Yue Yang
Institute of Cancer Prevention and Treatment, Harbin Medical University
Career Start Year
2015
Number of shared co-authors
0
Riccardo Campi
Careggi University Hospital
Career Start Year
2014
Number of shared co-authors
0
Zeyad R Schwen
Glickman Urological & Kidney Institute, Cleveland Clinic
Career Start Year
2013
Number of shared co-authors
0
David C Johnson
University of North Carolina School of Medicine
Career Start Year
2012
Number of shared co-authors
0
Giorgio Gandaglia
IRCCS San Raffaele Scientific Institute, Italy Vita-Salute San Raffaele University
Career Start Year
2012
Number of shared co-authors
0
Devin N Patel
university of california san diego School of Medicine
Career Start Year
2011
Number of shared co-authors
0
Ridwan Alam
Brady Urological Institute, Johns Hopkins University School of Medicine
Career Start Year
2010
Number of shared co-authors
0
Izak Faiena
Columbia University Medical Center
Career Start Year
2010
Number of shared co-authors
0
Shinji Ohtake
Institute of Urologic Oncology, University of California los angeles
Career Start Year
2010
Number of shared co-authors
0
Aydin Pooli
David Geffen School of Medicine, University of California los angeles
Career Start Year
2008
Number of shared co-authors
0
Joseph Brito
Yale School of Medicine
Career Start Year
2008
Number of shared co-authors
0
Michael A Liss
University of Texas Health San Antonio
Career Start Year
2008
Number of shared co-authors
0
Jonathan L Wright
University of Washington Medical Center
Career Start Year
2005
Number of shared co-authors
1
Amirali Salmasi
University of California San Diego
Career Start Year
2005
Number of shared co-authors
0
Derya Tilki
Universitatsklinikum Hamburg-Eppendorf
Career Start Year
2004
Number of shared co-authors
0
Lin Qi
Xiangya Hospital of Central South University
Career Start Year
2003
Number of shared co-authors
0
Alberto Briganti
IRCCS San Raffaele Scientific Institute
Career Start Year
2002
Number of shared co-authors
0
Karim Chamie
David Geffen School of Medicine at university of california los angeles
Career Start Year
2001
Number of shared co-authors
0
Girish S Kulkarni
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year
1999
Number of shared co-authors
0
Todd M Morgan
University of Michigan ann arbor
Career Start Year
1997
Number of shared co-authors
1
Surena F Matin
The University of Texas MD Anderson Cancer Center
Career Start Year
1997
Number of shared co-authors
0
Omer Acar
University of Illinois at Chicago
Career Start Year
1996
Number of shared co-authors
0
Douglas S Scherr
New York-Presbyterian Hospital
Career Start Year
1994
Number of shared co-authors
0
Antonio Finelli
Princess Margaret Cancer Centre, University Health Network and University of Toronto
Career Start Year
1993
Number of shared co-authors
0
Arnulf Stenzl
Eberhard Karls University of Tubingen
Career Start Year
1984
Number of shared co-authors
1
Hendrik Van Poppel
University Hospitals Leuven
Career Start Year
1981
Number of shared co-authors
0
row(s) 1 - 30 of 30
Collaborators
Cheol Kwak
Seoul National University Hospital, Seoul National University College of Medicine
Co-authored papers
190
Seok-Soo Byun
Seoul National University Bundang Hospital
Co-authored papers
64
Yong Hyun Park
James Buchanan Brady Urological Institute, Johns Hopkins School of Medicine
Co-authored papers
25
Seong Il Seo
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers
21
Seok Soo Byun
Seoul National University Bundang Hospital
Co-authored papers
17
Hyun Moo Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers
7
Choung-Soo Kim
Asan Medical Center, University of Ulsan College of Medicine
Co-authored papers
6
Ji Youl Lee
Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea
Co-authored papers
6
Jun Hyuk Hong
Asan Medical Center, University of Ulsan College of Medicine
Co-authored papers
5
Byung Ha Chung
Yonsei University College of Medicine and Gangnam Severance Hospital
Co-authored papers
5
Byong Chang Jeong
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers
4
Scarlett Lin Gomez
Co-authored papers
3
Yuzhuo Wang
University of British Columbia
Co-authored papers
2
In Young Choi
The Catholic University of Korea College of Medicine
Co-authored papers
2
Bhumsuk Keam
Seoul National University Hospital
Co-authored papers
1
Jae Moon Yun
Seoul National University Hospital
Co-authored papers
1
Soojin Lee
Co-authored papers
1
Sun Jung Lee
College of Medicine, The Catholic University of Korea
Co-authored papers
1
Sung Hye Yu
College of Medicine, Catholic University of Korea
Co-authored papers
1
Belong Cho
College of Medicine, Seoul National University
Co-authored papers
1
Mark J Dunning
The Medical School, The University of Sheffield
Co-authored papers
1
Jayoun Kim
Co-authored papers
1
Yejin Kim
University of Texas Health Science Center at Houston
Co-authored papers
1
Ilsa Coleman
Fred Hutchinson Cancer Center
Co-authored papers
1
Alastair D Lamb
University of Oxford
Co-authored papers
1
Sung-Min Kim
Co-authored papers
1
Colm Morrissey
Co-authored papers
1
1 - 27